Question 1

What are the potential benefits of using DefenCath® compared to the standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will my child need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of DefenCath®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

Question 4

How will you ensure my child’s safety during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my child does not qualify for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

Question 6

Can we continue other treatments while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age clinical trial (NCT06714864). Contact the study team or your healthcare provider for specific answers.

What this study is about